Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Gladstone Investment Corporation Announces Closing of Over-Allotment Option on Common Stock
-
Gladstone Investment Corporation Announces Closing of Over-Allotment Option on Common Stock
-
Opexa Therapeutics Reminds Shareholders That Rights Offering Expires on April 8, 2015 at 5:00 PM ET
-
Maxim Group Starts Lumenis (LMNS) at Buy
-
Applied DNA Sciences, Inc. Announces Closing of $12.0 Million Public Offering and Partial Exercise of Over-Allotment Option
-
Momenta Phama (MNTA)/Teva (TEVA) Takeover Rumor Doesn't Make Sense, Maxim Group Says
-
Remark Media (MARK) Announces 850k Direct Placement at $4/Share
-
Remark Media Announces $3.4 Million Registered Direct Offering
-
Maxim Group LLC Expands Equity Research Platform With the Appointment of Two Research Analysts
-
Maxim Group Downgrades Syntel, Inc. (SYNT) to Hold
-
Medivation (MDVN) PT Lifted to $163 at Maxim Group
-
Applied DNA Sciences (APDN) Prices 3.82M Share Common/Warrant Offering at $3
-
Applied DNA Sciences (APDN) Prices $11.46M Offering of Stock and Warrants
-
Applied DNA Sciences Prices $11.46 Million Public Offering
-
Applied DNA Sciences (APDN) Plans Common, Warrants Offering
-
Applied DNA Sciences Announces Proposed Public Offering
-
Attending Firms Announced for the Growth Capital Expo, April 12-14, 2015
-
Horizon Technology Finance Corporation Announces Completion of Public Offering of Common Stock
-
Unusual 11 Mid-Day Movers 3/23: (RADA) (MCP) (CAPN) Higher; (MEIP) (EXII) (LBIO) Lower
-
Vertex (VRTX) VX661/ivacaftor Phase II Fails to Impress in Homozygotes, Maxim Notes
-
Notable Analyst Rating Changes 3/23: (SPLS) (ELY) (NMM) Upgraded; (NVDA) (CCL) (SHW) Downgraded
-
Pre-Open Stock Movers 03/23: (MCP) (IMGN) (AAPL) Higher; (MEIP) (VRTX) (NVDA) Lower (more...)
-
Maxim Group Starts Capnia (CAPN) at Buy
-
TxCell to Present at Upcoming US and French Investment Conferences
-
Wheeler Real Estate Investment Trust, Inc. Completes Offering and Sale of $90 Million of Series C Convertible Preferred Stock
-
Horizon Technology Finance Corporation Prices Public Offering of Common Stock
-
Arlington Asset Investment Corp. Announces Closing of Senior Notes Offering
-
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants
-
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants
-
ADMA Biologics Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
-
The Alliance for Regenerative Medicine Releases Agenda for Third Annual Regen Med Investor Day
-
Asterias Biotherapeutics to Present at Regen Med Investor Day 2015
-
MiMedx to Present at 3rd Annual Regen Med Investor Day
-
Maxim Group Downgrades Synthetic Biologics (SYN) to Hold Amid Delays
-
Maxim Group Downgrades SFX Entertainment (SFXE) to Hold
-
Galena Biopharma (GALE) Prices 24.4M Common, Warrants Offering at $1.56/Unit
-
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ALS Data Shows Neuralstem (CUR) Approach is 'Risky' - Maxim Group
-
Arlington Asset Investment Corp. Announces Pricing of Senior Notes Offering
-
21 Listed Companies Participate at Capital Link's 9th Annual International Shipping Forum on Monday, March 23, 2015 -- New York City
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Arlington Asset Investment Corp. Announces Senior Notes Offering
-
Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants
-
Aeropostale (ARO) Price Target Removed at Maxim Group on Negative EBITDA Trends
-
Gladstone Investment (GAIN) Prices 3.3M Common Offering at $7.40/Share
-
Gladstone Investment Corporation Prices Common Stock Offering

